Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Peter Novodvorsky

8PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityElectrical energy generation (incl. renewables, excl. photovoltaics)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Dec 15, 2025
Insulin therapy DE-intensificAtion with iGlarLixi: A phase 4, open-label, parallel-group randomised controlled trial.

Peter Novodvorský, Lenka Thieme, Ivana Laňková

|Jul 28, 2025
Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed-ratio combinations of basal insulin and a glucagon-like peptide-1 receptor agonist.

Luděk Horváth, Peter Novodvorský, Martin Haluzík

|Feb 28, 2025
Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia.

Peter Novodvorsky, Alan Bernjak, Ellen Downs

|Apr 23, 2024
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.

Peter Novodvorský, Lenka Thieme, Ivana Laňková

|Jul 08, 2023
Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia.

Mariana Rončáková, Arash Davani, Veronika Mikušová

|Oct 13, 2021
An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus.

Peter Novodvorský, Martin Haluzík

Pageof 2

Frequent Collaborators

3 joint publications

Martin Haluzík

2 joint publications

Muhammad Fahad Arshad

1 joint publications

Emil Martinka

1 joint publications

Richard M Jacques

1 joint publications

Simon R Heller

1 joint publications

Luděk Horváth

Frequent Collaborators

3 joint publications

Martin Haluzík

2 joint publications

Muhammad Fahad Arshad

1 joint publications

Emil Martinka

1 joint publications

Richard M Jacques

Top Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

19.3K
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on : May 10, 2018

9.4K
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on : Jan 26, 2024

1.3K
See more related videos

Top Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

19.3K
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on : May 10, 2018

9.4K
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on : Jan 26, 2024

1.3K
See more related videos